Jiangsu Hengrui Pharmaceuticals Co., Ltd.
10% owner at Braveheart Bio; 10% owner at Kailera Therapeutics.
- Rank
- 506th of 809
- Companies held
- 2
- Largest holding
- BRVE, 85.9% of total
- Latest SEC filing
- Aug 7, 2026
- Listed but not counted
- $12
What the $167M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Braveheart Bio BRVE Common Stock | Directly | 7,420,091 | $19.27 | $143M | 85.9% | Form 4, Aug 7, 2026 |
| Kailera Therapeutics KLRA Common Stock | Directly | 2,034,133 | $11.58 | $23.6M | 14.1% | Form 4, Apr 20, 2026 |
Share counts are the amounts Jiangsu Hengrui Pharmaceuticals Co., Ltd. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Kailera Therapeutics KLRA Common Stock | Through Hengrui (USA) Ltd. Held by a company or fund the insider manages | 1 | $11.58 | $12 | — | Form 4, Apr 20, 2026 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 503 | ARG Private Equity, LLC Insider, StepStone Group | $168M |
| 504 | Trimaran Pollo Partners, L.L.C. 10% owner, El Pollo Loco Holdings | $168M |
| 505 | Bay Resource Partners LP 10% owner, Cracker Barrel Old Country Store | $167M |
| 506 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% owner, Braveheart Bio | $167M |
| 507 | Silver Lake Partners V DE (AIV), L.P. Director, Dell Technologies | $164M |
| 508 | Nea 14 Gp, LTD 10% owner, Enliven Therapeutics | $164M |
| 509 | Bay II Resource Partners LP 10% owner, Cracker Barrel Old Country Store | $164M |
Other Braveheart Bio insiders
All BRVE insiders- Travis Murdoch$141MCEO and President. #1160 overall
- David I. Malek$14.9MDirector. #6476 overall
- Christopher Viehbacher$14.6MDirector. #4810 overall
- James Paul Rickey$11.8MChief Financial Officer. #7757 overall
- Michele A. Anderson$6.4MChief Development Officer. #12189 overall
- Jason Coloma V.$1.8MDirector. #5362 overall
Questions
How much stock does Jiangsu Hengrui Pharmaceuticals Co., Ltd. own?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. holds $166,540,414 in listed stock based on SEC filings and current prices, mostly Braveheart Bio (BRVE). That ranks 506th on the Stock Rich List.
Is this Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.